Pluristem Therapeutics, Inc. (PLUR)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

2

(1)

15

0

4

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
20-Sep-24 4:00 PM View:	18-Sep-24 Grant 0	Franco-Yehuda Chen Chief Financial Officer		Pluristem Therapeutics, Inc. - PLUR	(43%) 117.72K to 67.5K	0	0	--	--	Show Txns Hide Txns

25-Jan-24 4:01 PM View:	23-Jan-24 Grant 0	Shemesh-Rasmussen Maital Director		Pluristem Therapeutics, Inc. - PLUR	191% 20.0K to 58.15K	0	0	--	--	Show Txns Hide Txns

25-Jan-24 4:01 PM View:	23-Jan-24 Grant 0	Levi Rami Avraham Director		Pluristem Therapeutics, Inc. - PLUR	185% 20.0K to 57.1K	0	0	--	--	Show Txns Hide Txns

25-Jan-24 4:01 PM View:	23-Jan-24 Grant 0	Birger Pinhas Doron Director		Pluristem Therapeutics, Inc. - PLUR	200% 20.0K to 59.9K	0	0	--	--	Show Txns Hide Txns

25-Jan-24 4:01 PM View:	23-Jan-24 Grant 0	Aberman Zami Director		Pluristem Therapeutics, Inc. - PLUR	3% 1.58M to 1.63M	0	0	--	--	Show Txns Hide Txns

20-Sep-24 4:00 PM View:	18-Sep-24 Grant 0	Yanay Yaky Chief Executive Officer Director		Pluristem Therapeutics, Inc. - PLUR	(81%) 1.77M to 333.59K	0	0	--	--	Show Txns Hide Txns

25-Jan-24 4:01 PM View:	23-Jan-24 Grant 0	Abony Lorne Kenneth Director		Pluristem Therapeutics, Inc. - PLUR	100% 0 to 36.75K	0	0	--	--	Show Txns Hide Txns